Caigang Xu
机构：Sichuan University, West China Hospital of Sichuan University · ORCID：0000-0003-0549-4065
发表论文 94 篇 · 总被引 457 次 · h-index 10
代表论文
- Efficacy and safety of PD-1/PD-L1 inhibitors for natural killer/T-cell lymphoma: a single-arm meta-analysis (2025 · BMC Cancer · 被引 7)
- Real-world clinical features and survival outcomes in diffuse large B-cell lymphoma patients with hepatitis B virus infection (2024 · Infectious Agents and Cancer · 被引 3)
- Predicting the efficiency of chidamide in patients with angioimmunoblastic T-cell lymphoma using machine learning algorithm (2024 · Frontiers in Pharmacology · 被引 2)
- Risk and prognosis of second primary malignancies in patients with follicular lymphoma in the era of rituximab: A population study based on the SEER database (2025 · PLoS ONE · 被引 1)
- Sustained yet non-curative response to lenalidomide in relapsed angioimmunoblastic T-cell lymphoma with acquired chidamide resistance: a case report with 10-year follow-up, genetic insights and literature review (2024 · Frontiers in Oncology · 被引 1)
- A Novel Conditioning Regimen Combining Selinexor with Melphalan Could Improve Survival of Patients with Multiple Myeloma (2024 · Blood · 被引 1)